
Taking a mental health leave from work is an option most people don't know about
NEW YORK (AP) — Her first panic attack came at a company-wide meeting, right before her scheduled presentation. Carolina Lasso had given many similar talks about her marketing team's accomplishments. When her name was called this time, she couldn't speak.
'I felt a knot in my throat,' Lasso said. 'My head, it felt like it was inside a bubble. I couldn't hear, I couldn't see, and it felt like an eternity. It was just a few seconds, but it was so profound, and in a way earth-shattering to me.'
Lasso was struggling after a cross-country move followed by a divorce. Her boss suggested a mental health leave, a possibility she didn't know existed. She worried whether taking time off would affect how her team viewed her or cost her a future promotion, but in the end she did.
'I'm thankful for that opportunity to take the time to heal,' Lasso, 43, said. 'Many people feel guilty when they take a leave of absence when it's mental health-related. … There is some extra weight that we carry on our shoulders, as if it had been our fault.'
Despite a fear of repercussions, more adults are recognizing that stepping back from work to deal with emotional burdens or psychological conditions that get in the way of their lives is a necessary choice, one that a growing number of employers recognize.
ComPsych Corp., a provider of employee mental health programs and absence management services, encourages its business clients to make the well-being of workers a priority before individuals get to a breaking point while also having processes in place for those who require leaves of absence.
'Since the start of the COVID-19 pandemic, collectively we've just been in this constant state of turmoil,' Jennifer Birdsall, the senior clinical director at ComPysch, said. 'We just have had this barrage of change and uncertainty.'
Depression, anxiety and adjustment disorder, which involves excessive reactions to stress, were the top three diagnoses of employees who took mental health leaves in the past two years among clients of Alight, a Chicago-based technology company which administers leaves and benefits for large employers.
Structuring a leave
A mental health leave can last weeks or months. In some cases, workers get approval to work a reduced schedule or to take short periods of time off when needed, using an approach called 'intermittent leave.'
At most U.S. organizations with 50 or more employees, people can request leaves through the Family and Medical Leave Act. The federal law entitles workers with serious health conditions to paid or unpaid leaves of up to 12 weeks, depending on state and local laws.
Some employers require people to use sick days or accumulated vacation days to continue receiving a paycheck while out. For longer leaves, workers can access short-term disability plans, if their employer offers one.
Lasso's leave lasted six months, and included therapy and travel to India for additional treatment. She returned to her job but decided after a year to leave for good. She later launched a business to train people on fostering a more humane work culture.
A mental health leave is 'not only OK, but it can really unlock new possibilities once we have the time to do the work — therapy, medication, whatever it is — and have enough distance from work to be able to reconnect with ourselves,' Lasso said.
Talking openly about struggles
A social stigma around mental health challenges causes many people to avoid seeking treatment or requesting a leave of absence. Newton Cheng, director of health and performance at Google, hopes to change that by sharing his own struggles.
His first self-disclosure happened during the pandemic, when a senior manager invited employees at a meeting to share how they were doing. When it was his turn, Cheng started crying.
He explained he was struggling to live up to his expectations of himself as a father and didn't know how to turn things around.
'It was just totally horrifying to me because, one, I had just cried in front of my coworkers and I was definitely taught as a professional — and as a man — you do not do that,' Cheng recalled. 'And then two, I had never really articulated and said out loud those words. I hadn't even allowed myself to think that. But now they're out there and I had to face them.'
Colleagues responded by relaying their own struggles, but Cheng's difficulties continued. By February 2021, he couldn't get out of bed because he felt paralyzed by dread, he said. A therapist said he was showing symptoms of major depression and anxiety.
'I just realized, 'I'm struggling a lot and this goes pretty deep. I don't think I can keep just putting duct tape on this. I probably need to take some leave,'' Cheng recalled.
Hoping his decision would benefit others, he announced to 200 people at a conference that he planned to take mental health leave. Instead of derailing the gathering as he feared, his honesty inspired fellow conference attendees to open up.
'It was like a fireworks show,' Cheng said. 'They're like, 'Wow, I can't believe he did that.' Then they forgot about me. But the tone was set. It was like 'Oh, this is what we're doing. Let me talk about what's going on with me, too.''
Take the time you need
While balancing classes and a full-time job during her last year of college, Rosalie Mae began struggling to get out of bed and crying uncontrollably. Yet she felt like she had 'to keep it together' to avoid burdening her colleagues at the University of Utah bookstore, where Mae worked as an accounting clerk.
Then she found herself calling a suicide hotline. 'Once it reached that point, I knew, especially at the urging of my husband, we need to do something more,' Mae, 24, said.
In her case, that meant taking a five-week work leave to put her own health and well-being first. She recommends the same for others who find themselves in a similar position.
'Taking a mental health leave is not necessarily a cure-all, but it is important to give yourself a break and allow yourself to regroup, make a plan of how to proceed and take the steps to work towards feeling better,' Mae said.
Telling managers and colleagues
Before broaching the subject of a mental health leave with a manager, consider the workplace culture and the strength of your professional relationships, Cheng said. He recalls saying, 'For my health and well-being, and the sake of my family and what's best for the business, the least risky thing for me to do is to go on leave soon.'
Individuals who suspect an unsympathetic reception can simply say, 'I need to go on medical leave. I need time to recover,' he advised.
There's also no legal or ethical requirement to tell everyone you work with the nature of your leave.
'Your coworkers don't need to know why,' said Seth Turner, co-founder of AbsenceSoft, a leave and accommodation management solutions provider. 'They just need to know, 'I'm going to be here at this time, and I'm going to be gone at this time, and I'll be back.''
___
Have you overcome an obstacle or made a profound change in your work? Send your questions and story ideas to cbussewitz@ap.org. Follow AP's Be Well coverage, focusing on wellness, fitness, diet and mental health at https://apnews.com/hub/be-well.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
10 minutes ago
- Yahoo
The reasons aren't fully clear, but overdose deaths are down in Kern, US
Overdose deaths, specifically from opioids, are on the decline across the nation and data from the Kern County Coroner's Office shows local deaths are down as well. According to KCSO, there were 189 fentanyl-related overdose deaths in Kern County in 2024, down from 297 in 2023, a roughly 36% decline. The decline is part of a broader trend nationally. Opioid overdose deaths declined sharply from 2023-2024, according to provisional data from the Centers for Disease Control and Prevention. According to the CDC, 48 states and the District of Columbia all saw decreases in overdose deaths from December 2023 to 2024, a 26% decrease nationwide. California's reported overdose deaths dropped by 24%, the most of any West Coast state. Only Nevada and South Dakota saw an increase in overdose deaths, both by less than 4%. It's not entirely clear what's driving the decline, and experts are pointing to a range of factors. "Over the past, I'd say this calendar year, we have seen an increase in the people who are coming into our treatment system," said Ana Olvera, an administrator with Kern Behavioral Health and Recovery Services. "More people have accessed our treatment system than in years past, even coming out of COVID, which is a good sign for us," Olvera said. The increased availability of treatment programs and the overdose reversal drug naloxone were likely contributors to the decrease, she said, as well as reduced stigma about seeking treatment. Olvera also pointed to the passage of Proposition 36, which increased penalties for certain crimes. "Just from that — working with the courts and people who are eligible for this program that have a treatment-mandated felony — we have seen an increase of folks who are eligible and who come into our system of care," Olvera said. BHRS and other health care providers have increased their treatment options, Olvera said. The county's 24-hour substances-use-disorder hotline, which helps connect people with treatment, has seen higher call volume over the years, she said. "The call center is how most people access treatment in our substance use system," Olvera said. The average number of calls has increased from 908 in the 2018-2019 fiscal year to 1,272 in 2023-2024. From July 2024 to April of this year, there were 1,061 calls. There's no doubt overdose deaths are dropping, but exactly why is still a matter of conjecture. The Opioid Data Lab at the University of North Carolina at Chapel Hill tracks information related to opioids and its researchers have said there's no single explanation for such a steep, nationwide decline in overdose deaths. "Ascribing a single national explanation for the drop in overdoses is not grounded in data," the lab said in a February analysis. Even with the large decline in deaths, the mortality rate from drug overdoses remains high, with most states still recording death rates higher than before the COVID-19 pandemic. Data from the CDC and the California Department of Public Health shows overdose deaths peaking in 2023 before dropping sharply in 2024. According to CDPH, Kern County's opioid-related overdose deaths reached an all-time high of 321 in 2023. That was up from 308 in 2022 and 274 in 2021. As of April 30, Kern had seen 50 fentanyl-related deaths so far this year, according to KCSO.
Yahoo
29 minutes ago
- Yahoo
RFK Jr.'s HHS Shakeup Spares Dr. Plescia, Backer Of Vaccine Credentials
Despite firing every member of the federal vaccine advisory committee, Health and Human Services Secretary Robert F. Kennedy Jr. has retained one key figure with a radically pro-passport past. Kennedy, who recently disbanded the Advisory Committee on Immunization Practices (ACIP), kept Dr. Marcus Plescia in a top post at HHS as Deputy Assistant Secretary and Director of the Office of Science and Medicine. Plescia's past comments in favor of vaccine passports place him well to the left of even the Biden White House's stance during the height of the COVID-19 pandemic. In 2021, Plescia — then serving as chief medical officer for the Association of State and Territorial Health Officials — told The New York Times that vaccine passport credentials were 'going to be necessary,' calling it 'perplexing' that the federal government was keeping its distance from such a proposal. His remarks came even as White House Press Secretary Jen Psaki assured reporters that 'there will be no federal vaccinations database and no federal mandate requiring everyone to obtain a single vaccination credential.' Plescia's position, made public at the time through The New York Times' reporting, stood in contrast not only to Biden's hesitancy but also to an ongoing wave of state-level opposition. Governors from Texas, Florida, and Mississippi issued orders banning or opposing any form of vaccine credentialing, arguing it violated basic liberties and privacy. Kennedy's implicit decision to retain contrasts with his other decisions. On June 9, the new health secretary made headlines for his sweeping removal of the 17-member ACIP panel, citing what he called a 'crisis of public trust' caused by conflicts of interest and pharmaceutical industry influence. 'The committee has become… little more than a rubber stamp for any vaccine. It has never recommended against a vaccine—even those later withdrawn for safety reasons.' Kennedy wrote in an op-ed for The Wall Street Journal, adding that many members had received 'substantial funding from pharmaceutical companies.' But the retention of Plescia — whose support for vaccine passports predates the Biden administration's relatively more cautious approach — raises questions. Plescia's 2021 endorsement of vaccine credentials aligned more with European-style digital health passes and apps like those trialed by Cathay Pacific Airlines and implemented by companies such as Walmart. 'There is going to have to be some kind of system where [vaccination status] is verified,' he said, arguing it was the only way to safely reopen businesses and restore public trust. The White House was unwilling to go that far at the time, concerned about the ethical implications and civil liberties involved. Instead, Psaki emphasized the government's position that any such system should 'meet key standards, including accessibility, affordability and privacy,' but would ultimately be left to the private sector. President Biden never fully implemented a vaccine passport system, but he did issue an executive order requiring nearly every private sector employee to get the COVID shot, which in turn prompted companies to create systems of verification for employees and customers. RFK Jr., a longtime COVID vaccine critic, ran a presidential campaign and later accepted his appointment to HHS on promises to dismantle what he called medical 'fascism.' His decision to purge the ACIP panel came after immense pressure from MAHA allies, including Dr. Mary Talley Bowden of Houston, who slammed the secretary for not taking more aggressive policy action to date, The Dallas Express reported. Kennedy's shakeup alarmed some congressional figures. Sen. Bill Cassidy (R-LA), a physician, said, 'Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion. I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case.' Kennedy was contacted for comment in the production of this story, but he did not respond. A spokesman for HHS did not immediately respond. Plescia's HHS bio describes his duties as follows: 'He advises the Assistant Secretary and OASH leadership across scientific and medical issues covering the full suite of public health priorities. He oversees staff and program work focused on state and federal health systems, infection-associated chronic conditions, vector borne disease, data-driven decision making and healthcare innovation.' The bio qualifies him for the job by saying, '[He] has widespread experience in medicine and public health. He is Board Certified in Family Medicine and practiced for over 20 years in a variety of settings serving homeless, urban poor and rural underserved populations.'
Yahoo
2 hours ago
- Yahoo
Doctors stunned to see strict exercise regimen is as good as medicine for colon cancer
Exercise really is as good as a drug, a groundbreaking new study found. In a global trial, workouts did better than pricey chemotherapy to prevent colon cancer recurrence. Oncologists gathered at the biggest annual cancer meeting in June gave the news a standing ovation. Scientists and doctors love to joke that exercise is a pretty great drug. But can workouts really compete with chemotherapy to prevent a disease like recurrent colon cancer? That's been tough to prove — until now. Results of the first randomized controlled trial of exercise as a treatment for recurrent high-risk cancer were presented at the American Society of Clinical Oncology's (ASCO) annual meeting in Chicago on June 1, and they stunned the crowd of doctors gathered there from around the world. The 17-year trial included over 880 patients from around the globe, each recovering from high-risk stage 2 or stage 3 colon cancer after treatment. Half of the participants were given general advice about exercise and how it can improve cancer survival. The other half were given a structured, three-year exercise prescription to follow, with the goal of preventing recurrence or a new cancer diagnoses. In the trial, exercise outperformed what adjuvant (or, secondary) chemotherapy can do to boost a patient's long-term survival, after surgery and primary treatment is over. Adjuvant cancer treatment is the kind designed to kill any extra cancer cells left behind, and prevent cancer from coming back. "Exercise is no longer just an intervention that improves quality of life and fitness. It is a treatment," Chris Booth, the study's lead author and a medical oncologist at Queen's University in Ontario, told the crowd. In the study, patients who followed an exercise regimen reduced their risk of death by 37%, and reduced their risk of cancer recurrence and new cancer development by 28%. The benefits of this three-year exercise prescription — which included advice and support from a trainer or physical therapist — were also long-lasting. After eight years, 90% of patients in the exercise program were alive compared to 83% in the control group. This 7% survival bump is comparable to (and in some cases exceeds) the survival benefits of standard drugs that doctors use in this same context. The common adjuvant chemotherapy drug oxaliplatin gives patients an overall survival boost of 5% after 10 years. Many other adjuvant cancer drugs deliver similar survival benefits, of around 5 to 10%. The effect didn't seem to be due to other factors. Patients didn't lose weight or belly fat, and no meaningful difference was seen in fatal heart attacks. The exercisers also weren't turning into Olympic athletes; they were just doing the equivalent of about 1.5 to 2.25 extra hours of brisk walking each week. In addition to reducing colon cancer diagnoses and deaths, the exercise also seemed to reduce the risk of other cancers. In the exercise group, there were two new cases of breast cancer diagnosed, compared to 12 cases among the controls. Other cancer doctors at the conference were shocked at the magnitude of the effect even though they've always kind of known exercise is good for cancer. Exercise is generally recommended to patients in recovery to improve outcomes. But to beat standard chemotherapy drugs? That was impressive. Dr. Paul Oberstein, a medical oncologist at NYU Langone who was not involved in the study, said he'd like to bring this treatment to his patients, maybe with some help from wearables like watches, and on-demand fitness classes people can access at home. "If you could somehow package this and bill it as a drug, it would be very valuable because the benefit was really remarkable," he said. Researchers are still studying the blood samples of patients who were in this study, drilling down into what might be driving the anti-cancer effects from exercise. Oberstein suspects that exercise is probably doing something that's powerfully anti-inflammatory in the body, reducing tumor growth, and preventing cancer's spread. At least, that's what he observes when he studies mice on treadmills in his lab. "Of course, mice on treadmills are not really people," he said, chuckling. "But what we see, and what we think might be applying, is that they have less inflammation." Other researchers think that perhaps exercise is revving up the immune system, engaging in what's called "immune surveillance" against cancer. "These are very hard things to measure over a long period of time," Oberstein said. Booth, who's been an avid long-distance runner ever since he was a kid, said this treatment should now be offered to any recovering colon cancer patient who wants it. "This intervention is empowering for patients, it is achievable for patients, and with a cost that is far lower than our standard," he said near the end of his talk. Slowly, but surely, the whole crowd stood up and burst into a sustained and hearty standing ovation. Read the original article on Business Insider